IGFBP2 mimetic peptide fragments (ALISBIO)

N/A

Report date: 2025/01/26 18:41:58

Base Information

Drug NameIGFBP2 mimetic peptide fragments (ALISBIO)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin-like growth factor binding protein II modulators
TargetsInsulin-like growth factor binding protein II
Therapy Area/IndicationsGenetic Diseases, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlisbio Llc
China Registration ClassN/A

Develop Information

Active CompaniesAlisbio Llc
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A